Beate Gleissner

902 total citations
20 papers, 620 citations indexed

About

Beate Gleissner is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Beate Gleissner has authored 20 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in Beate Gleissner's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Beate Gleissner is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Beate Gleissner collaborates with scholars based in Germany, United States and Austria. Beate Gleissner's co-authors include Marc C. Chamberlain, E. Thiel, A. Schilling, Richard Reinhardt, Agnieszka Korfel, Michael Seibold, Michael Pfreundschuh, Sandra Reichrath, Jörg Reichrath and E. Thiel and has published in prestigious journals such as Blood, Neurology and The Lancet Neurology.

In The Last Decade

Beate Gleissner

19 papers receiving 601 citations

Peers

Countries citing papers authored by Beate Gleissner

Since Specialization

Citations

This map shows the geographic impact of Beate Gleissner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Gleissner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Gleissner more than expected).

Fields of papers citing papers by Beate Gleissner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Gleissner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Gleissner. The network helps show where Beate Gleissner may publish in the future.

Co-authorship network of co-authors of Beate Gleissner

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Gleissner. A scholar is included among the top collaborators of Beate Gleissner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Gleissner. Beate Gleissner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines 2010 ·The Journal of Steroid Biochemistry and Molecular Biology ·Sandra Reichrath, F. Max Müller, Beate Gleissner, Michael Pfreundschuh, Thomas Vogt, Jörg Reichrath	23
2	Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling 2008 ·British Journal of Haematology ·Beate Gleissner, Ralf Küppers, Reiner Siebert, B. Glaß, Lorenz Trümper, Wolfgang Hiddemann, M. Dreyling	8
3	Successfully treatedCandida kruseiinfection of the lumbar spine with combined caspofungin/posaconazole therapy 2008 ·Medical Mycology ·A. Schilling, Michael Seibold, (unknown), Beate Gleissner	33
4	Treatment of CNS dissemination in systemic lymphoma 2007 ·Journal of Neuro-Oncology ·Beate Gleissner, Marc C. Chamberlain	23
5	Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials 2007 ·Oncology Research and Treatment ·Beate Gleissner, Richard F. Schlenk, Martin Bornhäuser, Wolfgang E. Berdel	9
6	Aspects of Chemotherapy Schedules in Young and Elderly Patients with Aggressive Lymphoma 2007 ·Clinical Lymphoma & Myeloma ·Carsten Zwick, Beate Gleissner, Michael Pfreundschuh	5
7	Neoplastic meningitis 2006 ·The Lancet Neurology ·Beate Gleissner, Marc C. Chamberlain	198
8	CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL) 2005 ·Blood ·Beate Gleissner	35
9	Improved Outcome of Zygomycosis in Patients with Hematological Diseases? 2004 ·Leukemia & lymphoma ·Beate Gleissner, A. Schilling, (unknown), (unknown), E. Thiel	166
10	Molecular genetic events in adult acute lymphoblastic leukemia 2003 ·Expert Review of Molecular Diagnostics ·Beate Gleissner, E. Thiel	4
11	CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes 2002 ·Neurology ·Beate Gleissner, (unknown), Agnieszka Korfel, Richard Reinhardt, E. Thiel	67
12	Analysis of chimerism during the early period after allogeneic peripheral stem cell transplantation 2001 ·Clinical & Laboratory Haematology ·Beate Gleissner, IW Blau, (unknown), Richard Reinhardt, Wolfgang Knauf, E. Thiel	3
13	Comparison of ethidium bromide-stained agarose gel electrophoresis and automated fragment analysis for evaluation of IgH gene products 2001 ·Leukemia Research ·Beate Gleissner, (unknown), (unknown), (unknown), Eckhard Thiel	8
14	Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies 2001 ·Expert Review of Molecular Diagnostics ·Beate Gleissner, E. Thiel	4
15	Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data 2001 ·Leukemia ·Beate Gleissner, Harald Rieder, E. Thiel, Christa Fonatsch, (unknown), B Heinze, J. W. G. Janssen, Claudia Schoch, Nicola Goekbuget, J. Mäurer, D. Hoelzer, (unknown)	18
16	Serological and nucleotide sequence analysis of HLA‐A6812 2000 ·Tissue Antigens* ·Ingrid Faé, Beate Gleissner, (unknown), Dominique Leitner, Gottfried Fischer	8
17	The sixth quality control exercise of the Central European tissue typing laboratories. 1998 ·PubMed ·(unknown), (unknown), (unknown), Beate Gleissner, Karen Wasilewski, (unknown)	0
18	Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer 1998 ·Oncology Research and Treatment ·Beate Gleissner, A. Hellmann, (unknown), Lutz Edler, Michael Koldehoff, A. Rost, (unknown), Dieter Fritze, (unknown)	1
19	Phase II trial of N-(phosphonacetyl)-l-aspartate (PALA), 5-fluorouracil and recombinant interferon-α-2b in patients with advanced gastric carcinoma 1996 ·European Journal of Cancer ·Scott Wadler, Beate Gleissner, (unknown), (unknown), Harry R. Haynes, (unknown), Alla M. Rozenblit, (unknown)	5
20	[Results of surgical treatment in osteochondritis dissecans. Collective report]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Beate Gleissner	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact